Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic painDavid Hewitt, Hao Wang, Tony W. Ho et al.|Pain|2010Cited by 63
Designing Phase 2 Trials Based on Program-Level Considerations: A Case Study for Neuropathic PainNitin Patel, José Cirı́aco Pinheiro, Arnold R. Gammaitoni et al.|Drug Information Journal|2012Cited by 28
Perioperative use of etoricoxib reduces pain and opioid side-effects after total abdominal hysterectomy: a double-blind, randomized, placebo-controlled phase III studyEugene R. Viscusi, Paul M. Peloso, Tara L. Frenkl et al.|Current Medical Research and Opinion|2012Cited by 26
The Pain Quality Response Profile of Pregabalin in the Treatment of Neuropathic PainMark P. Jensen, David Hewitt, Arnold R. Gammaitoni et al.|Clinical Journal of Pain|2011Cited by 18
Predicting Response to Pregabalin from Pretreatment Pain Quality: Clinical Applications of the Pain Quality Assessment ScaleArnold R. Gammaitoni, David Hewitt, Steven S. Smugar et al.|Pain Medicine|2012Cited by 16